PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-IIA

Hepion Reports Results of CRV431 in P-IIa AMBITION Trial for the Treatment of NASH

Hepion Reports Results of CRV431 in P-IIa AMBITION Trial for the Treatment of NASH

July 14, 2021

Urovant's Vibegron Fails to Meet its Primary Endpoint in P-IIa Study for IBS Pain

Urovant's Vibegron Fails to Meet its Primary Endpoint in P-IIa Study for IBS Pain

November 26, 2020

Bicycle Reports First Patient Dosing in P-IIa Study of BT1718 for MT1-MMP-Positive Squamous NSCLC

Bicycle Reports First Patient Dosing in P-IIa Study of BT1718 for MT1-MMP-Positive Squamous NSCLC

September 3, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us